The data collection form included several questions about the P&T committee, participants' involvement on the committee, and use of data from pharmacoeconomic studies by the P&T committee.

Sophia Humphreys, PharmD, MHA, BCBBS, director of system formulary management at Sutter Health, a market access strategist and biosimilar expert, emphasizes how these organizations have implemented ...

This study represents the first examination of how pharmaceutical industry representatives involved in marketing view the use of health outcome and pharmacoeconomic information by health care ...